TXNIP and glucose metabolism disease: Thioredoxin-interacting protein (TXNIP) is a key regulator of glucose metabolism disorders, cholesterol accumulation, and fatty acid synthesis in the liver (99), modulating ERS, and leading to hepatic steatosis and inflammation.